Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Emergent BioSolutions Canada Inc.
FDA Inspection
•Emergent BioSolutions Canada Inc.•May 12, 2026

Emergent BioSolutions Canada Inc. – FDA Inspection, May 12, 2026

Record Details

This FDA Inspection record concerns Emergent BioSolutions Canada Inc., with an inspection on May 12, 2026, issued by the Office of Inspections and Investigations, covering biologics.

Company
Emergent BioSolutions Canada Inc.
Inspection Date
May 12, 2026
Product Type
Biologics
Office
Office of Inspections and Investigations
People
  • Lewis K. Antwi (Issuing Officer)
  • Yonggang Wang (Company Rep)
View Company Profile

ID · 17acd2f3-4a76-4450-84f2-4575f2e7f499

Inspection Facts

Inspection number
1316698
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.160(a)Following/documenting laboratory controls
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.22(a)Authority lacking to review records, investigate errors
  6. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  7. 21 CFR 211.67(b)Written procedures not established/followed
  8. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  9. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Emergent BioSolutions Canada Inc.

8
DateClassificationOfficeProject area
August 27, 2025Not classifiedOffice of Inspections and Investigations
September 13, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 16, 2017VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
February 3, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 18, 2014VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 8 other inspections on the company page
Other documents for Emergent BioSolutions Canada Inc.
  • FDA Inspection 1280431 - 2025-08-27
  • FDA Inspection 1109095 - 2019-09-13
  • FDA Inspection 1018375 - 2017-05-16
  • FDA Inspection 918929 - 2015-02-03
  • FDA Inspection 905505 - 2014-07-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Emergent BioSolutions Canada Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.